Quantcast

Latest Carcinoma Stories

2014-04-17 23:01:36

Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug, Viagra (sildenafil citrate), which is marketed by the US-based pharmaceutical company, Pfizer. Toledo, OH (PRWEB) April 17, 2014 Studies have suggested that sildenafil use may increase the invasiveness of melanoma cells, which may raise the possible adverse effect of melanoma. On April 7, 2014, a...

2014-03-31 23:32:02

Bladder cancer patients with metabolic syndrome – a set of conditions closely related to diabetes risk – are more likely to have a more invasive and fast-growing form of the disease. Raleigh, NC (PRWEB) March 31, 2014 A team of Turkish urology specialists have concluded that bladder cancer is more likely to be of a higher stage and grade in patients who also suffer from metabolic syndrome or diabetes. The results of their new analysis have just been posted on the on Cancer Monthly...

2014-03-27 08:33:21

ORPINGTON, England, March 27, 2014 /PRNewswire/ -- Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, announces positive top line results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT. In the study, over 250 patients with clinically suspicious lesions for basal cell carcinoma were scanned...

2014-03-20 08:30:23

WOONSOCKET, R.I., March 20, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its composition of matter, biological targets, mechanism of action, and methods and formulations for therapeutic use. MCT-485 is a very small noncoding double stranded RNA (dsRNA) molecule which has demonstrated a unique cytotoxic, oncolytic, and immune stimulating activity in in vitro models of...

2014-03-04 23:30:56

The Sensus Healthcare SRT-100™ is a non-invasive skin cancer treatment system. The SRT-100™ will provide the local patient community with the most effective, non-surgical and pain free therapy to treat non-melanoma skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), which account for the vast majority of all skin cancers. Roslyn Heights, NY (PRWEB) March 04, 2014 Skin Cancer Radiotherapy Institute (SCRI) announced that they are the first medical...

2014-03-04 23:28:32

Treatments are Top Procedure in 2013 Rolling Meadows, IL (PRWEB) March 04, 2014 Not only are skin cancer treatments again the top procedure performed by American Society for Dermatologic Surgery members but the number of cases continues to rise, according to a recent ASDS survey. ASDS members performed more than 3 million skin cancer treatments in 2013, an increase of 13 percent from 2012, according to the 2013 ASDS Survey on Dermatologic Procedures released last month. Skin cancer is...

2014-03-04 12:26:52

Incentives for Pathway Compliance, Reduced Hospitalization are Changing Treatment, According to Findings from Decision Resources Group BURLINGTON, Mass., March 4, 2014 /PRNewswire/ -- Decision Resources Group finds that the increasing use of clinical pathway programs, accountable care organizations (ACOs) and bundled payments is changing the prescribing of oncology drugs in the treatment of colorectal cancer and renal cell carcinoma. As more payers and oncology practices adopt pathways,...

2014-02-26 08:29:54

LOS ANGELES, Feb. 26, 2014 /PRNewswire/ -- Los Angeles dermatologist, Dr. Peyman Ghasri, offers a variety of treatments for skin cancer. Skin cancer is the most common form of cancer in the United States today and can cause significant pain, disfigurement and death. Early identification and treatment of cancer is generally associated with more positive outcomes. About Dr. Peyman Ghasri, Skin Doctor Los Angeles Dr. Ghasri is a premier dermatologist. He graduated magna cum laude from...

2014-02-20 08:32:00

Primary Care Physicians will soon be able to test for basal cell carcinoma, the most common cancer in the US GARDEN CITY, N.Y., Feb. 20, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (OTCBB: MHCC) today announced that its subsidiary, Millennium Medical Devices LLC, has signed an exclusive agreement with CDx Diagnostics for distribution of DermCDx(TM) , a brush biopsy test kit that is used to confirm suspected basal cell carcinoma (BCC), the most common cancer in the US. DermCDx is...

2014-01-30 12:28:54

Study shows impact of educational programs and clinical tools on the treatment of renal cell carcinoma RESTON, Va., Jan. 30, 2014 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, along with its partners, the Annenberg Center for the Health Sciences and AXDEV Group, announced today that it will present key findings from a national educational needs assessment on renal cell carcinoma in a...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related